Your browser doesn't support javascript.
loading
Shared N417-Dependent Epitope on the SARS-CoV-2 Omicron, Beta, and Delta Plus Variants.
Moyo-Gwete, Thandeka; Madzivhandila, Mashudu; Mkhize, Nonhlanhla N; Kgagudi, Prudence; Ayres, Frances; Lambson, Bronwen E; Manamela, Nelia P; Richardson, Simone I; Makhado, Zanele; van der Mescht, Mieke A; de Beer, Zelda; de Villiers, Talita Roma; Burgers, Wendy A; Ntusi, Ntobeko A B; Rossouw, Theresa; Ueckermann, Veronica; Boswell, Michael T; Moore, Penny L.
Affiliation
  • Moyo-Gwete T; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
  • Madzivhandila M; MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Mkhize NN; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
  • Kgagudi P; MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Ayres F; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
  • Lambson BE; MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Manamela NP; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
  • Richardson SI; MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Makhado Z; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
  • van der Mescht MA; MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • de Beer Z; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
  • de Villiers TR; MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Burgers WA; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
  • Ntusi NAB; MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Rossouw T; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
  • Ueckermann V; MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Boswell MT; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
  • Moore PL; MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
J Virol ; 96(15): e0055822, 2022 08 10.
Article in En | MEDLINE | ID: mdl-35867572
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Cross Reactions / Spike Glycoprotein, Coronavirus / SARS-CoV-2 / Antibodies, Viral / Epitopes Type of study: Prognostic_studies Limits: Humans Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Cross Reactions / Spike Glycoprotein, Coronavirus / SARS-CoV-2 / Antibodies, Viral / Epitopes Type of study: Prognostic_studies Limits: Humans Language: En Year: 2022 Type: Article